Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen–Negative Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen–Negative Patients

Published:2018-06-09 Issue:9 Volume:218 Page:1480-1484
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Höner zu Siederdissen Christoph¹,Hui Aric Josun²,Sukeepaisarnjaroen Wattana³,Tangkijvanich Pisit⁴,Su Wei Wen⁵⁶,Nieto Gerardo Enrique Guillén⁷,Gineste Paul⁸,Nitcheu Josianne⁸,Crabé Sandrine⁸,Stepien Sandrine⁹,Manns Michael P¹¹⁰,Trépo Christian¹¹¹²,Wedemeyer Heiner¹¹⁰¹³,Cornberg Markus¹¹⁰

Affiliation:

1. Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover

2. Alice Ho Miu Ling Nethersole Hospital, Hong Kong, China

3. Khon Kaen University, Khon Kaen

4. Center of Excellence in Hepatitis and Liver Cancer, Chulalongkorn University, Bangkok, Thailand

5. Department of Gastroenterology, Changhua Christian Hospital, Changhua

6. School of Medicine, Chung Shan Medical University, Taichung, Taiwan, Republic of China

7. Centro de Ingeniería Genética y Biotecnología, Havana, Cuba

8. Abivax, Paris, France

9. Georges Institute, Sydney, Australia

10. German Center for Infection Research, Hannover-Braunschweig

11. Department of Hepatology, Groupement Hospitalier Nord, Hospices Civils de Lyon

12. Lyon University, France

13. Department of Gastroenterology and Hepatology, University Clinic Essen, Essen, Germany

Funder

Abivax

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/218/9/1480/26084130/jiy350.pdf

Reference13 articles.

1. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update;Sarin;Hepatol Int,2016

2. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;Lampertico;J Hepatol,2017

3. Discontinuation of oral antivirals in chronic hepatitis B: A systematic review;Papatheodoridis;Hepatology,2016

4. Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study;Berg;J Hepatol,2017

5. Viral and host responses after stopping long-term nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B;Höner zu Siederdissen;J Infect Dis,2016

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discontinuation of Nucleos(t)ide Analogues in HBeAg Negative Chronic Hepatitis B Patients: Risks and Benefits;Infectious Diseases and Clinical Microbiology;2024-06-28

2. Evaluation of chronic hepatitis B patients who voluntarily discontinued oral antiviral therapy: is there an answer to the controversial topic?;European Journal of Gastroenterology & Hepatology;2024-02-23

3. When to Stop Antiviral Therapy in HBeAg-Negative Patients with Chronic Hepatitis B?;Current Hepatology Reports;2024-02-23

4. Nucleos(t)ide analogs for hepatitis B virus infection differentially regulate the growth factor signaling in hepatocytes;Hepatology Communications;2024-01

5. Risk factors for relapse after discontinuation of tenofovir or entecavir in hepatitis B e antigen-negative patients;Hepatology Forum;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3